NCT01363336View on ClinicalTrials.gov

Post-marketing Surveillance for Hypertensive Patients With Diabetes and/or Chronic Kidney Disease

CompletedOBSERVATIONAL

Enrollment

1,882

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

June 30, 2013

Study Completion Date

July 31, 2013

Conditions

Hypertension

Interventions

DRUG

Nifedipine (Adalat CR, BAYA1040)

patients who are administrated with Adalat CR for hypertension

Trial Locations (1)

Unknown

Many Locations

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Bayer

INDUSTRY